Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 5.00 | 238.25 | 0.0210 | -0.9993 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 4.00 | 651.00 | 0.0061 | -0.9940 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 775.00 | 651.00 | 1.1905 | 1.4402 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 625.00 | 354.63 | 381.00 | 651.00 | 0.5853 | 0.0853 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 625.00 | 354.63 | 713.00 | 651.00 | 1.0952 | 1.2188 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 721.00 | 651.00 | 1.1075 | 1.2472 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 713.00 | 651.00 | 1.0952 | 1.2188 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 625.00 | 354.63 | 309.00 | 651.00 | 0.4747 | -0.1454 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 750.00 | 651.00 | 1.1521 | 1.3506 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 598.00 | 651.00 | 0.9186 | 0.8153 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 625.00 | 354.63 | 519.00 | 651.00 | 0.7972 | 0.5443 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 488.00 | 651.00 | 0.7496 | 0.4395 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 625.00 | 354.63 | 438.00 | 651.00 | 0.6728 | 0.2725 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 399.00 | 651.00 | 0.6129 | 0.1440 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 354.63 | 607.00 | 651.00 | 0.9324 | 0.8465 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 625.00 | 354.63 | 344.00 | 651.00 | 0.5284 | -0.0341 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 625.00 | 354.63 | 711.00 | 651.00 | 1.0922 | 1.2117 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 701.00 | 651.00 | 1.0768 | 1.1762 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 625.00 | 354.63 | 485.00 | 651.00 | 0.7450 | 0.4294 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 482.00 | 651.00 | 0.7404 | 0.4193 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 733.00 | 651.00 | 1.1260 | 1.2899 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 354.63 | 480.00 | 651.00 | 0.7373 | 0.4126 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 645.00 | 651.00 | 0.9908 | 0.9790 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 635.00 | 651.00 | 0.9754 | 0.9440 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 4.00 | 651.00 | 0.0061 | -0.9940 |